These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 116854)

  • 1. Idiotypic studies on myeloma B cells.
    Van Acker A; Conte F; Hulin N; Urbain J
    Eur J Cancer (1965); 1979 May; 15(5):627-35. PubMed ID: 116854
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal lymphocyte population in human plasma cell myeloma.
    Mellstedt H; Hammarström S; Holm G
    Clin Exp Immunol; 1974 Jul; 17(3):371-84. PubMed ID: 4219599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific detection of myeloma plasma cells using anti-idiotypic single chain antibody fragments selected from a phage display library.
    Willems PM; Hoet RM; Huys EL; Raats JM; Mensink EJ; Raymakers RA
    Leukemia; 1998 Aug; 12(8):1295-302. PubMed ID: 9697887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the immune response by idiotypic-antiidiotypic interactions.
    Geha RS
    N Engl J Med; 1981 Jul; 305(1):25-8. PubMed ID: 6164922
    [No Abstract]   [Full Text] [Related]  

  • 5. Major histocompatibility complex control of the idiotypic network in the MOPC 173 system.
    Boyer C; Schiff C; Milili M; Fougereau M
    Eur J Immunol; 1981 Oct; 11(10):769-76. PubMed ID: 6171432
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients.
    Bergenbrant S; Yi Q; Osterborg A; Björkholm M; Osby E; Mellstedt H; Lefvert AK; Holm G
    Br J Haematol; 1996 Mar; 92(4):840-6. PubMed ID: 8616076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of MOPC-167 growth in vivo by immunization against the idiotype of the MOPC-167 myeloma protein.
    Sakato N; Hall SH; Eisen HN
    Microbiol Immunol; 1979; 23(9):927-31. PubMed ID: 317126
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigen-binding myeloma cells: monoclonal models of B cell differentiation.
    Lynch RG; Rohrer JW; Gebel HM; Odermatt BF; Hoover RG; Milburn GL; Mordhorst R
    Prog Clin Biol Res; 1980; 42():325-44. PubMed ID: 6994115
    [No Abstract]   [Full Text] [Related]  

  • 9. Idiotype-bearing and antigen-binding receptors produced by blood T lymphocytes in a case of human myeloma.
    Preud'homme JL; Klein M; Labaume S; Seligmann M
    Eur J Immunol; 1977 Dec; 7(12):840-6. PubMed ID: 75800
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in lymphocyte surface immunoglobulins in myeloma and the effect of an RNA-containing plasma factor.
    Chen Y; Bhoopalam N; Yakulis V; Heller P
    Ann Intern Med; 1975 Nov; 83(5):625-31. PubMed ID: 812401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
    Moshitzky S; Kukulansky T; Haimovich J; Hollander N
    Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.
    Kubagawa H; Vogler LB; Capra JD; Conrad ME; Lawton AR; Cooper MD
    J Exp Med; 1979 Oct; 150(4):792-807. PubMed ID: 92518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of multiple immunoglobulin classes by single lymphocytes.
    Pernis B; Forni L; Luzzati AL
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 1():175-83. PubMed ID: 408086
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular handling of a monoclonal anti-idiotypic antibody in IgA-producing MOPC 315 mouse myeloma cells.
    Marks A; Baumal R; Ahmad A
    Anticancer Res; 1984; 4(3):183-8. PubMed ID: 6331799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and cross-reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma.
    Wen YJ; Ling M; Lim SH
    Br J Haematol; 1998 Mar; 100(3):464-8. PubMed ID: 9504627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics, expression, and function of idiotypes.
    Rajewsky K; Takemori T
    Annu Rev Immunol; 1983; 1():569-607. PubMed ID: 6399979
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-DNA autoantibody activity and idiotypic relationships of human monoclonal proteins.
    Zouali M; Fine JM; Eyquem A
    Eur J Immunol; 1984 Dec; 14(12):1085-9. PubMed ID: 6440794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypes on B lymphocytes: association with immunoglobulins.
    Victor C; Bona C; Pernis B
    J Immunol; 1983 Apr; 130(4):1819-25. PubMed ID: 6187821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of surface-bound antibody accompanying the anti-complementary modulation of leukemic B cell immunoglobulin: contrasting effects of antibodies directed against idiotypic and constant regions.
    Gordon J; Anderson VA; Stevenson GT
    J Immunol; 1982 Jun; 128(6):2863-9. PubMed ID: 6804570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of monoclonal anti-idiotypic antibody to P3-X63Ag8 myeloma protein for analysis and purification of B lymphocyte hybridoma products.
    Gheuens J; McFarlin DE
    Eur J Immunol; 1982 Aug; 12(8):701-3. PubMed ID: 6982818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.